• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.

作者信息

Saad M J, Moreira A C, Foss M C

机构信息

Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brasil.

出版信息

Braz J Med Biol Res. 1990;23(10):953-7.

PMID:2129261
Abstract

This study was designed to determine the relationship between endogenous hyperinsulinemia or free fatty acid (FFA) levels and the abnormal release of growth hormone (GH) during the oral glucose tolerance test (OGTT) or in response to thyrotropin releasing hormone (TRH) in acromegalic patients. Seventeen patients with acromegaly and nine healthy control subjects were studied. The 12 acromegalic patients who did not show the paradoxical response of increased GH secretion to the OGTT and/or to TRH exhibited higher insulin levels (total area under the curve during the OGTT) than patients who did. However, the FFA levels of the groups of acromegalic patients were similar. These data suggest that the endogenous hyperinsulinemia exhibited by many patients with acromegaly is associated with the absence of the paradoxical increase in GH secretion during the OGTT and/or after TRH.

摘要

相似文献

1
Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
Braz J Med Biol Res. 1990;23(10):953-7.
2
Impaired glucose tolerance coincides with abnormal release of growth hormone following a glucose load as well as in response to TRH in acromegaly.糖耐量受损与肢端肥大症患者葡萄糖负荷后以及对促甲状腺激素释放激素(TRH)反应时生长激素的异常释放同时出现。
Horm Metab Res. 1986 Jun;18(6):400-1. doi: 10.1055/s-2007-1012326.
3
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.肢端肥大症患者术前对促甲状腺激素释放激素的生长激素反应及口服葡萄糖耐量试验:50例患者的回顾性评估
Metabolism. 2002 May;51(5):616-21. doi: 10.1053/meta.2002.32017.
4
Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?“所谓的”正常生长激素浓度(2 - 5微克/升)是否表明肢端肥大症已治愈?
Horm Metab Res. 1995 Apr;27(4):185-8. doi: 10.1055/s-2007-979936.
5
The control on growth hormone release by free fatty acids is maintained in acromegaly.在肢端肥大症中,游离脂肪酸对生长激素释放的控制仍然存在。
J Clin Endocrinol Metab. 1999 Apr;84(4):1234-8. doi: 10.1210/jcem.84.4.5618.
6
Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.肢端肥大症患者生长激素(GH)分泌对生长激素释放激素、促甲状腺激素释放激素、促性腺激素释放激素及生长抑素反应的研究。
J Clin Endocrinol Metab. 1986 Jul;63(1):167-73. doi: 10.1210/jcem-63-1-167.
7
Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.人胰腺生长激素释放激素-44对肢端肥大症患者生长激素(GH)分泌的影响:与促甲状腺激素释放激素及溴隐亭的比较
J Clin Endocrinol Metab. 1985 Jan;60(1):48-52. doi: 10.1210/jcem-60-1-48.
8
Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.肢端肥大症患者中生长激素对肽组氨酸甲硫氨酸的矛盾反应:与促甲状腺激素释放激素和血管活性肠肽作用的比较
J Clin Endocrinol Metab. 1991 May;72(5):982-5. doi: 10.1210/jcem-72-5-982.
9
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.肢端肥大症患者中,纯生长激素(GH)垂体腺瘤和生长激素/催乳素混合垂体腺瘤对胍法辛、溴隐亭和促甲状腺激素释放激素的生长激素分泌反应不同。
J Clin Endocrinol Metab. 1985 Jun;60(6):1148-53. doi: 10.1210/jcem-60-6-1148.
10
Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.使用善得定(SMS 201-995)对肢端肥大症进行长期治疗。多数异常生长激素反应恢复正常。
Acta Endocrinol Suppl (Copenh). 1987;286:9-18.